Answers are grounded in this paper and cite their sources.
Lipoprotein [a] (Lp[a]) is a cholesterol-rich lipoprotein resembling LDL to which a large polymorphic glycoprotein, apolipoprotein [a] (apo[a]), is covalently coupled. Lp[a] usually exists as a free-standing particle in normolipidemic subjects; however, it can associate noncovalently with triglyceride-rich lipoproteins in hypertriglyceridemic (HTG) subjects. In this study, 10–78% of the Lp[a] present in five HTG subjects was found in the triglyceride-rich lipoprotein (TRL) fraction. The Lp[a]-TRL complex was resistant to dissociation by ultracentrifugation (UCF) alone, but was quantitatively dissociated by UCF in the presence of 100 mM proline. Of this dissociated Lp[a], 70–88% was in the form of a lipoprotein resembling conventional Lp[a]. Incubation of Lp[a]-depleted TRL with native Lp[a] resulted in a reconstituted Lp[a]-TRL complex that closely resembled the native isolates in all examined properties. Complex formation was inhibited by several compounds in the order proline > tranexamate > ε-aminocaproate >> arginine > lysine. Neither plasminogen nor LDL inhibited binding of Lp[a] to TRL. We observed the preferential binding of Lp[a] containing higher apparent molecular weight apo[a] polymorphs to TRL both in native and reconstituted Lp[a]-TRL complexes. A disproportionate amount of Lp[a] was bound to the larger TRL particles. Although most apo[a] bound to TRL was in the form of conventional Lp[a] particles, lipid-free recombinant apo[a] was observed to bind TRL. These results provide unequivocal evidence of the existence of an Lp[a]-TRL complex under pathophysiologic conditions. The metabolic fate of the Lp[a]-TRL complex, which is more abundant in hypertriglyceridemia, may be different from that of conventional Lp[a], and may contribute uniquely to the progression or severity of cardiovascular disease.—Gaubatz, J. W., R. C. Hoogeveen, A. S. Hoffman, K. G. Ghazzaly, H. J. Pownall, J. Guevara, Jr., M. L. Koschinsky, and J. D. Morrisett. Isolation, quantitation, and characterization of a stable complex formed by Lp[a] binding to triglyceride-rich lipoproteins. J. Lipid Res. 2001. 42: 2058–2068. Lipoprotein [a] (Lp[a]) is a cholesterol-rich lipoprotein resembling LDL to which a large polymorphic glycoprotein, apolipoprotein [a] (apo[a]), is covalently coupled. Lp[a] usually exists as a free-standing particle in normolipidemic subjects; however, it can associate noncovalently with triglyceride-rich lipoproteins in hypertriglyceridemic (HTG) subjects. In this study, 10–78% of the Lp[a] present in five HTG subjects was found in the triglyceride-rich lipoprotein (TRL) fraction. The Lp[a]-TRL complex was resistant to dissociation by ultracentrifugation (UCF) alone, but was quantitatively dissociated by UCF in the presence of 100 mM proline. Of this dissociated Lp[a], 70–88% was in the form of a lipoprotein resembling conventional Lp[a]. Incubation of Lp[a]-depleted TRL with native Lp[a] resulted in a reconstituted Lp[a]-TRL complex that closely resembled the native isolates in all examined properties. Complex formation was inhibited by several compounds in the order proline > tranexamate > ε-aminocaproate >> arginine > lysine. Neither plasminogen nor LDL inhibited binding of Lp[a] to TRL. We observed the preferential binding of Lp[a] containing higher apparent molecular weight apo[a] polymorphs to TRL both in native and reconstituted Lp[a]-TRL complexes. A disproportionate amount of Lp[a] was bound to the larger TRL particles. Although most apo[a] bound to TRL was in the form of conventional Lp[a] particles, lipid-free recombinant apo[a] was observed to bind TRL. These results provide unequivocal evidence of the existence of an Lp[a]-TRL complex under pathophysiologic conditions. The metabolic fate of the Lp[a]-TRL complex, which is more abundant in hypertriglyceridemia, may be different from that of conventional Lp[a], and may contribute uniquely to the progression or severity of cardiovascular disease. —Gaubatz, J. W., R. C. Hoogeveen, A. S. Hoffman, K. G. Ghazzaly, H. J. Pownall, J. Guevara, Jr., M. L. Koschinsky, and J. D. Morrisett. Isolation, quantitation, and characterization of a stable complex formed by Lp[a] binding to triglyceride-rich lipoproteins. J. Lipid Res. 2001. 42: 2058–2068. The human lipoprotein [a] (Lp[a]) antigen, apolipoprotein [a] (apo[a]), was first discovered by Berg (1Berg K. A new serum type system in man: the Lp-system.Acta Pathol. Microbiol. Scand. 1963; 59: 369-382Google Scholar) and initially was thought to represent a variant of LDL. This specific apo[a] protein has been detected in plasma in several physical forms: i) lipid-free, unbound protein, ii) lipid-free protein disulfide linked to apoB-100, iii) disulfide linked to apoB-100 in an Lp[a] particle, and most recently, iv) associated with a triglyceride-rich lipoprotein (TRL) fraction. Apo[a] is usually present in human plasma as the cholesterol-rich Lp[a] particle but it has been detected in all of the above-mentioned forms. Lp[a] occurs ubiquitously, although the levels can vary 1,000-fold among individuals. Considerable clinical interest was first generated by qualitative tests that demonstrated a highly significant positive correlation between the presence of apo[a] in plasma and particular indicators of coronary heart disease (2Dahlen G. Frick M.H. Berg K. Valle M. Wiljasalo M. Further studies of Lp(a) lipoprotein/pre-beta1-lipoprotein in patients with coronary heart disease.Clin. Genet. 1975; 8: 183-189Google Scholar, 3Kostner G.M. Avogaro P. Cazzolato G. Marth E. Bittolo-Bon G. Qunici G.B. Lipoprotein Lp(a) and the risk for myocardial infarction.Atherosclerosis. 1981; 38: 51-61Google Scholar). Subsequent isolation, purification, and characterization of Lp[a] showed that it differed from LDL by the presence of the unique, polymorphic, high molecular weight, apo[a] protein that was disulfide linked to apoB-100 (4Gaubatz J.W. Heideman C. Gotto Jr., A.M. Morrisett J.D. Dahlen G.H. Human plasma lipoprotein(a).J. Biol. Chem. 1983; 258: 4582-4589Google Scholar, 5Uttermann G. Weber W. Protein composition of Lp(a) lipoprotein from human plasma.FEBS Lett. 1983; 154: 357-361Google Scholar). Further studies demonstrated a high amino acid sequence homology between apo[a] and kringle domains in plasminogen (6McLean J.W. Tomlinson J.E. Kuang W-J. Eaton D.L. Chen E.Y. Fless G.M. Scanu A.M. Lawn R.M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.Nature. 1987; 330: 132-137Google Scholar). A variable number of repeats of a plasminogen kringle IV-like structure in apo[a] accounts for its molecular weight polymorphism (6McLean J.W. Tomlinson J.E. Kuang W-J. Eaton D.L. Chen E.Y. Fless G.M. Scanu A.M. Lawn R.M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.Nature. 1987; 330: 132-137Google Scholar). These developments have broadened the search for possible pathological roles for Lp[a] to include thrombosis in addition to atherosclerosis (7Howard G.C. Pizzo S.V. Lipoprotein(a) and its role in atherothrombotic disease.Lab. Invest. 1993; 69: 373-386Google Scholar, 8Scanu A.M. Structural basis for the presumptive atherothrombogenic action of lipoprotein(a). Facts and speculations.Biochem. Pharm. 1993; 46: 1675-1680Google Scholar). Kringle structures possess specific ligand-binding properties, with documented binding sites for l-lysine and related amino acid analogs (9Ernst A. Helmhold M. Brunner C. Petho-Schramm A. Armstrong V.W. Muller H-J. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32–36 of human apolipoprotein(a).J. Biol. Chem. 1996; 270: 6227-6234Google Scholar, 10Gabel B.R. May L.F. Marcovina S.M. Koschinsky M.L. Lipoprotein(a) assembly quantitative assessment of the role of apo(a) kringle IV types 2–10 in particle formation.Arterioscler. Thromb. Vasc. Biol. 1996; 16: 1559-1567Google Scholar). Ten distinctive kringle IV types have been found in apo[a]; certain types have been identified in the specific noncovalent interaction with apoB-100, which is the first step in Lp[a] particle assembly. This ability of kringles to interact with particular macromolecules confers many important properties on the proteins in which they occur. Several in vitro studies have indicated that Lp[a] has an for lipoproteins Lawn R.M. of apolipoprotein(a) with apolipoprotein Biol. Chem. Scholar, Lipoprotein(a) binding to apolipoprotein containing Scholar, The binding of lipoproteins to human J. triglyceride-rich lipoproteins. Jr., in lipoproteins of that in apolipoprotein(a) and that in Invest. Scholar) first apo[a] associated with lipoproteins in studies of found as as of the apo[a] TRL of subjects with in subjects apolipoprotein in the triglyceride-rich lipoprotein of human subjects a Lipid Res. Scholar, lipoprotein of apolipoprotein(a) in the and Scholar). In the plasma of subjects with type or C. G. J. G. of apolipoprotein(a) in the plasma from patients with lipoprotein and with type Invest. Scholar) or IV E. J. J. is present in the triglyceride-rich in type IV 1993; Scholar) of apo[a] found associated with TRL with normolipidemic subjects; however, the of apo[a] was in the Lp[a] of A more of type IV detected of apo[a] TRL with in normolipidemic subjects C. S. J. of Lp(a) apo(a) with triglyceride-rich lipoproteins of human Scholar). The lipoprotein from several of subjects was and or protein of resulted in dissociation of most of the apo[a]; this dissociated apo[a] the and properties of Lp[a], evidence that Lp[a]-TRL lipoprotein Lp[a] noncovalently bound to TRL. The of apo[a] the TRL in and the of dissociation of Lp[a] from this complex have the of a native for the of this complex i) an to or of Lp[a] from its the of and ii) of the Lp[a] to for or Lp[a] levels related to levels in hypertriglyceridemic (HTG) patients W. G. Jr., plasma levels of in patients with Scholar, A. H. G. of on serum J. Invest. Scholar, G. S. G. and in a 1993; a possible metabolic between Lp[a]-TRL and showed that that in a in Lp[a] levels M. K. levels in different of 1993; 42: Scholar). of as resulted in a in Lp[a] M. C. E. Lp[a] Scholar). in normolipidemic or HTG subjects in with in Lp[a], which to levels G.M. of Lp(a) with Scholar, D. J. C. Fless G.M. Scanu A.M. between apo[a] and Lp[a] in subjects with different apo[a] a and a Lipid Res. Scholar). this Lp[a] the TRL in the form of a in Lp[a] of to in by J.D. M.L. M. and on in Scholar). the existence and of a native Lp[a]-TRL complex and to this physical form of Lp[a], have examined the plasma of hypertriglyceridemic subjects Valle D. of Scholar). with HTG to the of and The of Lp[a]-TRL to dissociation by by or by a of was the of the a of amino and analogs for ability to the Lp[a]-TRL and binding to the of several different on the and dissociation of the Lp[a]-TRL HTG subjects for this and was on a A normolipidemic was as a a of plasma was from by the was as a to the plasma to a of 100 In the plasma was in and mM in subjects a form by the for Human of and its of the TRL HTG plasma was to with ultracentrifugation (UCF) to the formation of a or in the that and quantitative of this fraction. of plasma in a for for a was TRL as all lipoproteins and Although all subjects in Lp[a] was from plasma of with apo[a] polymorphs as by on as J.W. Jr., J. M.L. W. Morrisett J.D. of human and of molecular to plasma levels of lipoprotein Lipid Res. Scholar). was for of native lipoproteins and from plasma or and for of Lp[a]-TRL generated in vitro from of Lp[a] and plasma or TRL. with mM 100 mM mM to of plasma or TRL was on a of or a of the of reconstituted particles, a of was a of the Lp[a] of and 100 with lipoprotein with 100 mM proline to bound Lp[a] or containing of for this of was was in the of for J. E. J. for the of serum with Chem. 1983; J. for of Chem. and E. G. E. P. W. for the of serum with Chem. Scholar) by the Lipid LDL was by the and D. of the of lipoprotein in of the Chem. Scholar) and for the of Lp[a] of serum on of lipoprotein by the Chem. which is Lp[a] Lp[a] protein levels by an in this and J.W. Morrisett J.D. and characterization of human lipoprotein Scholar). The of the was by of with higher to this Lp[a]. levels by as the This was to apoB-100 in and Lp[a] and to in The molecular of apo[a] polymorphs by a of an K. J.W. M. Koschinsky M. Morrisett J.D. of Lp[a] and risk for in and Lipid Res. 42: Scholar, S.M. Identification of apolipoprotein(a) of apolipoprotein(a) between and Res. 1993; Scholar). This high which of apo[a] that by kringle IV apo[a] polymorphs by with apo[a] containing and kringle IV repeats from TRL that been with 100 mM proline and to bound Lp[a] or apo[a] was to native Lp[a] in The was for with by or of an with 100 of protein a of and for a of was as a for this Lp[a] was observed to bind to of Lp[a] the basis of this as of Lp[a] for with A to Lp[a], for apo[a] by and with LDL and was for with as The of subjects in The in which the plasma for was a of the plasma to the presence of in the the of The protein of Lp[a] apo[a] and by for subjects was with and apo[a] of in TRL to the number of kringle type IV repeats in in to the number of kringle type IV repeats in in to the number of kringle type IV repeats in in a new The of Lp[a] the TRL in subjects from in the normolipidemic to as high as in the hypertriglyceridemic patients The of the Lp[a]-TRL complex was examined by the TRL from the UCF to as in for five of subjects. the and in all by with the results as the of UCF a dissociation of Lp[a] from the The TRL by a UCF Lp[a] a by a but more Lp[a] by 100 mM proline was in with a UCF resulted in dissociation of Lp[a] from the TRL. The proline of this and the of 100 mM proline with 100 mM ε-aminocaproate and for is in The of plasma Lp[a] that was the TRL from with mM proline to with mM and to with 100 mM proline. was more as a but complex as a of complex in the a UCF in the presence of or UCF of Lp[a]-TRL in the presence of 100 mM proline was found to be an the quantitative dissociation of Lp[a], this to of this form of Lp[a], present in be for the Lp[a]-TRL from an UCF was to 100 mM proline and the more of the Lp[a], of TRL. The of plasma from a from which of this Lp[a] be for This was for apo[a] from the HTG subjects levels conventional was This with the plasma Lp[a] levels of HTG and of apo[a] polymorphs by conventional This was by the proline and in of TRL and Lp[a] from proline of the apo[a] that bound to the Lp[a]-TRL for all subjects two subjects and plasma two apo[a] the levels of two in plasma with the of two polymorphs in the and (Lp[a]) is This a preferential of the larger apparent molecular weight apo[a] the TRL fraction. the apo[a] in the TRL was present as apo[a] protein or Lp[a] the of this dissociated Lp[a] was to and The and for apo[a] by this of this apo[a] was as In of this detected of a to apo[a] of the detected apo[a] to higher apparent molecular weight with the of of apo[a] polymorphs present in Lp[a]-TRL complexes. of plasma containing apo[a] polymorphs of kringle the represent Lp[a] dissociated by proline of Lp[a]-TRL from hypertriglyceridemic subjects to and a normolipidemic Apo[a] polymorphs from normolipidemic of hypertriglyceridemic demonstrated a number of identified on the basis of apparent molecular weight between the of TRL and proline and the present and The proteins dissociated from the Lp[a]-TRL by UCF in the presence of 100 mM proline in The the of the represent apo[a] and and the molecular weight A was plasma or resulted in The for plasma from is in Lp[a]-TRL in LDL in and the plasma proteins in and in the between LDL and lipid-free Lp[a] with its The for all subjects. the of was in the HTG subjects in the normolipidemic with the most of the Lp[a] with the TRL fraction. A amount of Lp[a] as apo[a] with plasma protein or the for The amount of Lp[a] in the Lp[a]-TRL complex be to plasma was with 100 mM proline and dissociation of Lp[a] from the TRL was observed 100 mM proline was in the in which of the Lp[a] was from the complex the Lp[a]-TRL complex by UCF was in the of the Lp[a] associated with the to the and as Lp[a] or the TRL bind Lp[a], Lp[a] was to plasma or TRL as in plasma in this was to was a in the amount of Lp[a] bound to as an amount or as the The complex formed by addition of Lp[a] to a to that of native Lp[a], apo[a] was to the Lp[a]-TRL complex from this and all of the Lp[a] associated with the TRL In of Lp[a] to a amount of the by The and for and was for binding the of Lp[a] of Lp[a]-TRL complex A was as a more and for the of a large number of on Lp[a]-TRL complex formation and The amount of for the and the of Lp[a] which its binding to was the 100 with of protein the Lp[a] binding to this was a to of Lp[a] This was to the of a number of different amino and related analogs on Lp[a]-TRL complex of to mM in the by the of the The was to the of The of complex formation was observed with proline and but was by and and in Lp[a] binding to TRL. and for ability to complex present the that Lp[a] was to the plasminogen binding and LDL was the of Lp[a] binding to of different apparent molecular weight polymorphs of apo[a] and recombinant apo[a] to was to apo[a] polymorphs of different molecular binding to and to lipid-free apo[a] is for complex the binding properties of Lp[a] containing apo[a] with or kringles and of a recombinant apo[a] with kringles The binding of high and apparent molecular weight polymorphs to was of Lp[a] protein was to of and the of Lp[a] associated with the TRL in the was by of the Lp[a] containing the apparent molecular weight apo[a] was bound with of the Lp[a] with high apparent molecular weight and of the recombinant apo[a] containing A number of have the of a of apo[a] with a TRL of a or in the plasma of with the of apo[a] in the TRL and its have have found of the plasma apo[a] a TRL it binding to molecular between apo[a] and TRL or it of the TRL with Lp[a]. The of Lp[a] for the has been documented in a of studies by Lawn R.M. of apolipoprotein(a) with apolipoprotein Biol. Chem. Scholar, Lipoprotein(a) binding to apolipoprotein containing Scholar, The binding of lipoproteins to human J. Scholar). studies on in vitro or with in evidence for a native a native complex has been of its structure has been to to the of Lp[a]-TRL in most normolipidemic subjects. a has an native Lp[a]-TRL and its characterization C. S. J. of Lp(a) apo(a) with triglyceride-rich lipoproteins of human Scholar). that the apo[a] associated with TRL was in the form of noncovalently bound Lp[a]. of UCF or the Lp[a]-TRL complex was and In the present study, have the of apo[a] in the TRL and it in to a more characterization with to physical and binding properties. We have and UCF to the that a particular for of Lp[a]-TRL its formation or In the present study, the of the plasma Lp[a] that was associated with a TRL from in a normolipidemic to in a hypertriglyceridemic The Lp[a]-TRL complex from was resistant to dissociation by UCF or was evidence of high binding In a UCF step in the presence of 100 mM proline resulted in dissociation of Lp[a]. Lp[a] with TRL by noncovalent which and by proline. between specific kringles of apo[a] and apoB-100 have been demonstrated B.R. Koschinsky M.L. apolipoprotein(a) kringle IV types bind to lipoprotein and noncovalent of apo(a) with can be in by and proline B.R. Koschinsky M.L. the amino of its noncovalent with Thromb. Vasc. Biol. Scholar, C. H. J. J. Structural domains of apolipoprotein(a) and its interaction with apolipoprotein in the Scholar). In the present study, and proline in Lp[a] from in with The dissociation of Lp[a] from TRL was on proline the The of proline as a of of with the of a specific of apo[a] with a proline of in TRL. A number of more proline have evidence that proline by have found that proline the binding of apo[a] to apoB-100 in vitro Lawn R.M. of apolipoprotein(a) with apolipoprotein Biol. Chem. Scholar). In a of of the in vitro assembly of Lp[a], tranexamate and proline two of the most although order of was from that found for Lp[a] binding to TRL S. S. K. G.M. for the in vitro assembly of Thromb. Vasc. Biol. Scholar). of native plasma the existence of an Lp[a]-TRL complex by a of Subsequent and of the Lp[a]-TRL resulted in dissociation of Lp[a] from the Lp[a]-TRL complex as by The Lp[a]-TRL complex was resistant to dissociation by proline in with 100 mM proline was in the in which of the Lp[a] was from The particle by Lp[a] was the TRL as by or This Lp[a] with the larger TRL the of the These larger TRL may have a a larger number of binding sites for Lp[a], in a of large with bound Lp[a] or more Lp[a] bound A number of represent in the TRL from of particle, the for the that the with more of bound 100 mM proline with UCF the quantitative dissociation of apo[a] and Lp[a] from this was for of of dissociated by UCF that of the apo[a] was in the form of Lp[a] and was in the form of lipid-free This lipid-free represent apo[a] alone, of apo[a] or an of the Lp[a]-TRL molecular weight with the presence of but a to These results the that most of the apo[a] bound to TRL is in the form of Lp[a] In addition to a for the of Lp[a] from the Lp[a]-TRL complex, UCF with 100 mM proline a TRL of Lp[a], which be for in vitro binding of the proteins dissociated from Lp[a]-TRL by this in addition to apo[a] and apoB-100, to and In a to the apparent molecular weight of was observed as has been to have a high for TRL E. G.M. The binding of to human serum Lett. Scholar). was found to bind Lp[a] by interaction with kringle IV type of apo[a] S. E. G. G. interaction of apolipoprotein(a) with by the kringle IV Scholar). or of the dissociated proteins the binding of apo[a] to a in the of the for binding Lp[a] in the be is of Lp[a] in both and it that an role in the formation or of the Lp[a]-TRL The preferential of TRL for the higher apparent molecular weight polymorphs of apo[a] in Lp[a] has been D. J. C. Fless G.M. Scanu A.M. between apo[a] and Lp[a] in subjects with different apo[a] a and a Lipid Res. Scholar). This was in the present in HTG and normolipidemic subjects two apo[a] polymorphs detected in and the apo[a] from both plasma and TRL be of a of apo[a] polymorphs in the TRL that differed from that in plasma and the The in apo[a] was with the preferential binding of the higher apparent molecular weight of apo[a] to the TRL. The binding of high apparent molecular weight apo[a] polymorphs to TRL that was detected in native isolates was in vitro by the binding of Lp[a] containing apparent molecular weight apo[a] to to the in Lp[a] containing the higher apparent molecular weight apo[a] polymorphs bound to the TRL. repeats of kringle IV for the molecular weight polymorphism of binding of the higher apparent molecular weight apo[a] an of this kringle type in the binding to TRL. recombinant with an apparent molecular weight that of the apo[a] polymorphs in of the Lp[a] in this bound the TRL in higher This that kringle IV in addition to kringle IV type may be in Lp[a] but in the recombinant and contribute to the this kringle IV types possible B.R. May L.F. Marcovina S.M. Koschinsky M.L. Lipoprotein(a) assembly quantitative assessment of the role of apo(a) kringle IV types 2–10 in particle formation.Arterioscler. Thromb. Vasc. Biol. 1996; 16: 1559-1567Google Scholar). the of apo[a] for TRL binding in with for the Lp[a] protein In the apo[a] bound to TRL was in the form of the Lp[a]. In vitro the of TRL to bind Lp[a]. Lp[a] was with plasma from an HTG and the was more apo[a] was bound to the TRL fraction. This the native resulted in an Lp[a]-TRL complex that i) was stable to ii) was dissociated by UCF in 100 mM iii) the native iv) by in and a for higher apparent molecular weight apo(a) In the binding of Lp[a] to TRL was inhibited by and in the order of as action on the native Lp[a]-TRL by and which kringles highly homologous to in the binding of Lp[a] to In plasminogen was detected by among the proteins dissociated from Although Lp[a] has been to with plasminogen for binding to for binding to TRL can be to plasminogen in the present The amino acid sequence between apo[a] and plasminogen to TRL In to the binding two and binding of Lp[a] to TRL. These of disulfide action that may protein that a more interaction between Lp[a] and TRL D. Lipoprotein(a) by Scholar). In a related of the binding of Lp[a] to it was observed that and all the of Lp[a] for W. and compounds the binding of to a between and Scholar). is the TRL for apo[a] binding as by this and the of on the TRL particle may be a that confers the ability to bind Lp[a]. that in LDL as the TRL in by metabolic Gotto Jr., A.M. of lipoproteins by the lipoprotein in human Biol. Chem. 1983; 258: Scholar). Although the of Lp[a] for and has been demonstrated by binding to or by native or have been as have demonstrated for Lipoprotein(a) binding to apolipoprotein containing Scholar, D.L. of and containing lipoproteins with lipoprotein(a).J. Biol. Chem. Scholar). in vitro studies found that as more for apo[a] The of Lp[a] for the apoB-100 the of LDL or is in that stable complex is the larger of which the of the TRL in have the for Lp[a] as by larger the basis of this the of in and from to to be to a in for Lp[a]. observed that bind more Lp[a] particle but apoB-100, this that the binding to the of The documented correlation between plasma Lp[a] and levels and the observed in Lp[a] with TRL a metabolic Lp[a]-TRL is more Lp[a] from the plasma this the observed S.M. Morrisett J.D. and of lipoprotein Scholar). plasma Lp[a] in by this to a risk for atherosclerosis in the Lp[a]-TRL complex is by the The lipoprotein Lp(a) is and in a by the Invest. Scholar) have demonstrated that the human can and Lp[a], a by in human the two provide for Lp[a] and the These the high of Lp[a] apo[a] in coronary J.W. M.L. D. Morrisett J.D. and of [a] and in coronary E. D. D. M.L. J.W. Morrisett J.D. Lipoprotein(a) in and from patients with Genet. and D. Morrisett and S. the both the apo[a] of Lp[a] and the apoB-100 of its for the Lp[a]-TRL complex may be for of the may to of Lp[a] and of This was in by from the and from the apolipoprotein [a] apolipoprotein apolipoprotein the protein of Lp[a] apo[a] and acid protein hypertriglyceridemic lipoprotein [a] lipoprotein lipoprotein complex triglyceride-rich lipoprotein with 100 mM proline to bound Lp[a] or apo[a] triglyceride-rich lipoprotein ultracentrifugation
No takes yet. Share an insight, caveat, or question.
Gaubatz et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: